Achieve Life Sciences, Inc. (ACHV) Deep Dive Video
Summary
Achieve Life Sciences is a high-risk, high-upside clinical-to-commercial nicotine-cessation bet, with cytisinicline’s superior tolerability and vaping first-mover potential offset by manufacturing, regulatory, dilution, and launch-execution risks.